HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muriel Giansily-Blaizot Selected Research

Apoferritins

10/2023A newly identified ferritin L-subunit variant results in increased proteasomal subunit degradation, impaired complex assembly, and severe hypoferritinemia.
4/2013Homozygous mutation of the 5'UTR region of the L-Ferritin gene in the hereditary hyperferritinemia cataract syndrome and its impact on the phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Muriel Giansily-Blaizot Research Topics

Disease

10Hemorrhage
01/2024 - 04/2002
3Hemophilia A (Haemophilia)
03/2020 - 05/2016
3Factor VII Deficiency (Hypoproconvertinemia)
05/2016 - 02/2003
2Anemia
10/2023 - 11/2022
2Iron Deficiencies
10/2023 - 11/2005
2Iron Overload
10/2023 - 12/2007
2Thrombosis (Thrombus)
08/2019 - 10/2012
2Epistaxis (Nosebleed)
11/2005 - 04/2002
1Polycythemia (Erythrocytosis)
12/2022
1Hypoxia (Hypoxemia)
12/2022
1Hemolysis
10/2018
1hereditary Xerocytosis
10/2018
1hereditary Hyperferritinemia with congenital cataracts
04/2013
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
10/2012
1Disease Susceptibility (Diathesis)
10/2012
1Hemochromatosis (Bronze Diabetes)
12/2007
1Hyperferritinemia
12/2007
1type 2 Hemochromatosis
12/2007
1beta-Thalassemia (Cooley's Anemia)
12/2007
1Menorrhagia
11/2005
1Contusions
11/2005
1Hemophilia B (Haemophilia B)
07/2002
1Hemorrhagic Disorders (Hemorrhagic Diathesis)
03/2002

Drug/Important Bio-Agent (IBA)

7Factor VII (Proconvertin)IBA
01/2020 - 04/2002
3Blood Coagulation Factors (Coagulation Factor)IBA
10/2023 - 11/2014
3factor VII clotting antigenIBA
06/2004 - 03/2002
2IronIBA
10/2023 - 10/2018
2ApoferritinsIBA
10/2023 - 04/2013
2Ferritins (Ferritin)IBA
10/2023 - 12/2007
2Hemostatics (Antihemorrhagics)IBA
10/2023 - 06/2004
2beta-Globins (beta Globin)IBA
12/2022 - 12/2007
2Hemoglobins (Hemoglobin)IBA
12/2022 - 11/2022
2Factor VIIa (Activated Factor VII)IBA
12/2017 - 05/2016
2AntibodiesIBA
05/2016 - 07/2002
25' Untranslated Regions (5' UTR)IBA
04/2013 - 12/2007
2Peptides (Polypeptides)IBA
12/2007 - 07/2002
1Fibrinogen (Factor I)FDA Link
01/2024
1AntigensIBA
01/2024
1Oxygen (Dioxygen)IBA
12/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2022
1hemoglobin AgrinioIBA
11/2022
1ThrombinFDA Link
08/2019
1recombinant FVIIa (rFVIIa)FDA Link
12/2017
1CoagulantsIBA
10/2012
1Transferrin Receptors (Transferrin Receptor)IBA
12/2007
1Antimicrobial PeptidesIBA
12/2007
1HepcidinsIBA
12/2007
1Transferrin (beta 2 Transferrin)IBA
12/2007
1metal transporting protein 1 (ferroportin)IBA
12/2007
1Nonsense Codon (Nonsense Mutation)IBA
02/2003

Therapy/Procedure

5Therapeutics
10/2023 - 04/2002
2Minor Surgical Procedures (Minor Surgery)
11/2005 - 04/2002
1Operative Surgical Procedures
10/2012